Nua Surgical Secures €6.5M to Revolutionize Maternal Health Care

Nua Surgical, a Galway-based medical device company focused on maternal health innovations, recently announced the successful close of a €6.5 million Series A funding round. The financing was led by EQT Life Sciences, along with Kidron Capital, Texas Medical Center Venture Fund (TMCVF), Enterprise Ireland, and several angel investors. This milestone puts Nua Surgical in a great position to advance its flagship product, SteriCISION, a revolutionary device designed to improve Caesarean section procedures.

Innovating C-Section Care with SteriCISION

The SteriCISION device is a first-of-its-kind, self-retaining surgical retractor designed to be used for C-section surgeries. SteriCISION differs from the traditional retractor because it is specifically designed to pay attention to the specific needs for these procedures. It improves surgical efficiency and reduces the chance of infection and complications. With over 20 million C-sections each year worldwide, the need for such an innovation in the field of maternal care and safety is indeed great.

Strategic Use of Proceeds

The newly raised funds will be critical in pushing Nua Surgical over regulatory barriers and into the early stages of commercialization. The company aims to secure key approvals, such as FDA clearance, while expanding its market presence, especially in the U.S. and Europe. The financing will also support further clinical research in proving the efficacy and safety of the device, as well as investments in scaling production and marketing efforts.

Support from Leading Investors

EQT Life Sciences, a global investor focused on health economics, saw the transformational potential of Nua Surgical’s innovations. Their participation, along with contributions from TMCVF and Kidron Capital, underlines the growing interest in maternal health technologies. Enterprise Ireland’s continued support underlines the growth of Ireland’s medtech ecosystem and the strategic role it plays in developing startups that address global healthcare challenges.
A Vision for Safer Births
Founded by Padraig Maher and his team, Nua Surgical emerged from the BioInnovate Ireland programme at the University of Galway. The company has always concentrated on improving surgical tools to enhance maternal care. This funding round is a big step toward realizing its vision of providing safer, more efficient childbirth experiences worldwide.

With tools like SteriCISION, Nua Surgical will cover the gaps in clinical productivity, as well as support the reduction of disparities in maternal health outcomes. It perfectly fits in the strategies globally creating advancements in surgical care and patient experience.

Future Ahead

As the company moves into its next phase, it stands as a shining example of innovation in women’s healthcare. With a solid funding base and a product poised to disrupt standard practices, Nua Surgical is a prime example of the potential of targeted medtech solutions in addressing critical health challenges.

This funding success reinforces the importance of investing in maternal health technologies, a sector often overlooked despite its profound societal impact. As Nua Surgical moves forward, it has the potential to redefine surgical standards for one of the most common and complex procedures in modern medicine.